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Background: Stress, depression, and anxiety affect 15% to 25% of pregnant women. However, substantial barriers to
psychosocial assessment exist, resulting in less than 20% of prenatal care providers assessing and treating mental
health problems. Moreover, pregnant women are often reluctant to disclose their mental health concerns to a
healthcare provider. Identifying screening and assessment tools and procedures that are acceptable to both women
and service providers, cost-effective, and clinically useful is needed.
Methods/Design: The primary objective of this randomized, parallel-group, superiority trial is to evaluate the feasibility and
acceptability of a computer tablet-based prenatal psychosocial assessment (e-screening) compared to paper-based screening.
Secondary objectives are to compare the two modes of screening on: (1) the level of detection of prenatal depression and
anxiety symptoms and psychosocial risk; (2) the level of disclosure of symptoms; (3) the factors associated with feasibility,
acceptability, and disclosure; (4) the psychometric properties of the e-version of the assessment tools; and (5) cost-
effectiveness. A sample of 542 women will be recruited from large, primary care maternity clinics and a high-risk antenatal
unit in an urban Canadian city. Pregnant women are eligible to participate if they: (1) receive care at one of the recruitment
sites; (2) are able to speak/read English; (3) are willing to be randomized to e-screening; and (4) are willing to participate in
a follow-up diagnostic interview within 1 week of recruitment. Allocation is by computer-generated randomization. Women
in the intervention group will complete an online psychosocial assessment on a computer tablet, while those in the control
group will complete the same assessment in paper-based form. All women will complete baseline questionnaires at the
time of recruitment and will participate in a diagnostic interview within 1 week of recruitment. Research assistants
conducting diagnostic interviews and physicians will be blinded. A qualitative descriptive study involving healthcare
providers from the recruitment sites and women will provide data on feasibility and acceptability of the intervention. We
hypothesize that mental health e-screening in primary care maternity settings and high-risk antenatal units will be as or more
feasible, acceptable, and capable of detecting depression, anxiety, and psychosocial risk compared to paper-based screening.
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Introduction
Depression and anxiety are among the most common
morbidities in pregnancy and postpartum (up to 1 year
post-delivery), with prevalence rates of 13% to 29% [1-3].
Without early screening and treatment, 50% to 70% of
women with prenatal anxiety or depression symptoms
[4] will experience persistent symptoms through their
child’s early years [5,6] with enduring effects on their
children’s development and mental health [7-9]. Psychi-
atric illness is also the leading cause of maternal mortal-
ity in Western countries [10]. However, perinatal mental
health problems are severely underdetected and under-
treated [11,12]. Without standardized screening, 80% of
cases remain undetected [13,14].
While screening is important, there are significant bar-
riers that prevent the majority of pregnant and postpartum
women from seeking mental healthcare and disclosing
concerns. These include the stigma of mental health, lack
of understanding of whether symptoms are abnormal or a
typical pregnancy experience, having providers or support
persons underestimate their symptoms and concerns, and
fear that reporting symptoms will lead others to think that
they will be an incompetent mother, prevent the majority
of pregnant and postpartum women from seeking mental
healthcare and disclosing concerns [15-19]. Although such
barriers may prevent women from accessing support on
their own, only 4% of women refuse mental health screen-
ing when offered by healthcare providers [20,21].
Despite recommendations [22,23] and high acceptance
by women [24-26] and providers [27-30], only 20% of peri-
natal providers conduct proactive screening as part of pre-
natal care [31] and less than 15% of pregnant/postpartum
women receive the help they need [32]. A systematic re-
view conducted by our team (manuscript in preparation)
found that substantial personal and system barriers to rou-
tine screening exist for healthcare providers, including fear
of women’s responses to screening, lack of time, lack of ac-
curate assessment tools and knowledge of their interpret-
ation, and lack of referral processes and options [20,33,34].
Taken together, this body of research underscores the
need to identify screening and assessment tools and pro-
cedures that are acceptable to both women and service
providers, overcome barriers to implementation, and are
cost-effective and clinically useful. The most effective peri-
natal mental health screening and management programs
are those characterized by screening incorporated into
routine care with designated systems of referral and treat-
ment that are initiated immediately after screening [35].
The potential impact of e-screening
Routine, standardized screening significantly improves
detection of mental health problems [13,14]. However,
the scarcity of human health resources poses a majordeterrent to routine screening. E-screening has the po-
tential to increase efficiency of mental healthcare by re-
allocating limited human resources where they are most
needed - in-depth follow-up assessment, referral, and
treatment. It is a low-resource option [36,37] that can be
embedded in current prenatal and postpartum care
across various settings and providers (for example, mid-
wives, nurses, obstetricians, family physicians) and thus
will increase access to routine screening.
Importantly, e-screening can address the most prom-
inent barriers to screening identified by pregnant women
and healthcare providers. Several studies report that e-
screening for sensitive issues such as prenatal/postnatal
intimate partner violence [38-40] and postpartum de-
pression [41] is acceptable and feasible. It is well-suited
for busy clinical settings in that it offers consistency, can
be tailored to patient needs, can be used with audio/
video for low literacy, provides real-time data [36,37],
achieves similar or greater rates of disclosure compared
to interviews, and is preferred by patients due to its ano-
nymity [37,38,42,43]. To date, no studies have evaluated
e-screening in pregnant women, yet screening that in-
creases access to early prenatal intervention may reduce
the risk of prenatal and postpartum depression/anxiety,
as well as adverse child outcomes. One small study that
examined the psychometric properties and rates of de-
tection of postpartum depression of two Internet-based
screening tools found that both tools (Edinburgh Postnatal
Depression Scale; The Postpartum Depression Screening
Scale) had excellent validity and reliability with prevalence
rates within range of other self-report and interview-based
assessment approaches [41].
There is a clear need for a rigorous evaluation of the
feasibility, acceptability, and psychometric performance
of e-screening for prenatal mental health difficulties. A
key consideration for evaluation is to determine whether
established assessment tools are valid and reliable for
use when delivered online. For example, it has been
shown that some tools have different psychometric
properties when delivered online, suggesting a need for
different cutoff points [44]. Another key issue is the in-
clusion of women experiencing a broad range of degrees
of psychosocial risk. Pregnant women with high-risk
pregnancies represent a vulnerable group in that the
prevalence of mental health problems in this group is
more than three times greater than medically low-risk
women [45,46]; however, medically high-risk women are
rarely included in intervention studies of perinatal men-
tal health.
Screening versus psychosocial assessment
Screening is defined as the use of a symptom-based tool,
and psychosocial assessment is the combined use of a
screening tool plus an assessment of psychosocial risk
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the Internet to collect and transfer data from a psycho-
social assessment.
Purpose
Objectives, research questions, and hypotheses
Primary objective
The primary objective of the study is to determine preg-
nant women’s and healthcare providers’ views of the
feasibility and acceptability of mental health e-screening
compared to paper-based screening.
Secondary objectives
The five secondary objectives are to compare the two
modes of screening on: (1) the level of detection of pre-
natal depression and anxiety symptoms and psychosocial
risk; (2) the level of disclosure of symptoms; (3) the factors
associated with the acceptability, feasibility, and disclosure;
(4) psychometric properties (sensitivity, specificity, posi-
tive and negative predictive values) of the e-version of the
Antenatal Psychosocial Health Assessment (ALPHA) and
Edinburgh Postnatal Depression Scale (EPDS) when ad-
ministered to medically low- and high-risk pregnant
women; and (5) cost-effectiveness of screening.
Research questions and hypotheses
The specific research questions and hypotheses corre-
sponding to the primary and secondary objectives are
described in Table 1. Overall, we hypothesize that mental
health e-screening in primary care maternity settings and
high-risk antenatal units will be as or more feasible, ac-
ceptable, and capable of detecting depression, anxiety, and
psychosocial risk compared to paper-based screening.
Methods/Design
Study design
The study is a parallel-group, randomized, controlled su-
periority trial (RCT) with a qualitative descriptive compo-
nent (Figure 1). This design is well-suited for answering
questions of effectiveness, acceptability, and feasibility [47].
In this trial, physicians and all research assistants conduct-
ing diagnostic interviews are blinded. We adhered to
CONSORT guidelines in the design of the trial [45,46] and
the SPIRIT guidelines [48,49] in reporting its details in this
protocol. Approval for this study was granted by the
Human Research Ethics Board at the University of Alberta.
Randomized controlled trial
Eligibility criteria
Pregnant women are eligible for this study if they: (1) re-
ceive care at one of the recruitment sites; (2) are able to
speak/read English; (3) are willing to be randomized to
e-screening; and (4) are willing to participate in a follow-
up diagnostic interview within 1 week of recruitment.Setting
Recruitment of pregnant women will take place at ma-
ternity clinics in a large, urban Canadian city and an in-
patient, high-risk antenatal unit in a tertiary care
hospital. Medically high-risk pregnant women have sig-
nificantly higher rates of depression and anxiety than
low risk women [45,46]. Thus, recruiting women with
low and high medical risk will enable us to evaluate the
effectiveness of e-screening to accurately detect symp-
toms of depression, anxiety, and psychosocial risk across
the spectrum of low to high symptom prevalence and se-
verity. All sites serve a sociodemographically diverse
population. At the maternity clinics, family physicians
specializing in obstetrics provide full obstetrical care (for
example, all prenatal, delivery, and postpartum care) and
shared care (for example, they provide prenatal care up
to 28 weeks and then care is transferred to an obstetri-
cian). The high-risk antenatal unit is a 24-bed inpatient
unit in a large, tertiary care hospital with over 5,900
births per year. It is the only inpatient acute hospital in
the community and surrounding region for women with
high-risk pregnancies, and women receive care primarily
from obstetricians. The majority of family physicians,
obstetricians, and nurses at the recruitment sites do not
have specialized training in mental healthcare.
Recruitment procedures, consent, randomization, and
allocation procedures
Recruitment procedures are similar across sites. Trained
staff at the recruitment sites will use a standardized script
to determine each eligible (see Eligibility criteria) woman’s
interest in study participation. Women will be referred to
an onsite research assistant who will provide the tablet.
Women will complete the consent electronically on the tab-
let and receive the automatically generated copy via email.
The research assistant will be available to answer questions
about study participation and tablet logistics. A simple,
computer-generated randomization process designed by
the Women’s and Children’s Health Research Institute
(WCHRI) at the University of Alberta allocates women (1:1
ratio) automatically to the control or intervention group,
and they will receive a ‘pop-up’ message informing them
that they will complete questions about emotional health
on paper (control group) or tablet (intervention group).
Computerized randomization preserves allocation conceal-
ment and reduces the possibility of selection bias since the
research assistant is kept unaware of the group assignments
until after the participants are allocated to groups.
The intervention
The intervention is psychosocial assessment via elec-
tronic administration. Women assigned to the interven-
tion group will complete the psychosocial assessment
comprising the ALPHA and the EPDS electronically
Table 1 Primary and secondary objectives, research questions, and hypotheses
a
Primary objective Research question Outcome Measures Testable hypothesis
To compare the feasibility and acceptability
of mental health e-screening versus
paper-based screening.
Is mental health e-screening as or
more feasible and acceptable to
pregnant women and their healthcare
providers than paper-based screening?
Feasibility: % women in intervention
and control groups reporting that
screening is easily done as a
component of routine prenatal
care; mean CAE score
Quantitative: Mean CAE scores and % of women
responding affirmatively to questions of
feasibility and acceptability will be similar
or significantly higher in the intervention
group (indicating greater feasibility/
acceptability) compared to the control
group
Feasibility
Example (CAE): I liked/would
like using the tablet to answer
these questions
Acceptability: % of participants in
intervention and control groups
reporting that screening is
acceptable; % of participants
reporting that questions about
emotional health were easy to
understand and easy to navigate
around on the tablet
Acceptability
Example: (1) I did not/would
not like answering questions





Secondary objective Research question Outcome Measure Testable hypotheses
1. To compare the level of detection of
symptoms of prenatal depression, anxiety,
and psychosocial risk in e-screening versus
paper-based screening
Compared to paper-based screening,
what is the effect of mental health
e-screening in pregnant women on
the detection of prenatal depression,
anxiety, and psychosocial risk?
Proportion of women scoring
above cutoff point of EPDS for
depression and anxiety; proportion
of women identified as some or
high psychosocial risk on ALPHA
EPDS Compared to the control group, a higher
proportion of women in the intervention
group will: (1) score 13 or more on the
total EPDS (corresponding to probable
prenatal depression); (2) score 4 or more
on the anxiety subscale of the EPDS
(Q3, 4, 5) (corresponding to probable
prenatal anxiety); and (3) be identified as
having some/moderate or high
psychosocial risk on the ALPHA
ALPHA
2. To compare the level of disclosure of
symptoms of prenatal depression and
anxiety, and psychosocial risk in e-screening
versus paper-based screening
Compared to paper-based screening,
what is the effect of mental health
e-screening in pregnant women on
the disclosure of prenatal depression,
anxiety, and psychosocial risk?
Level of disclosure: Mean subscale
scores: (1) risk of disclosure;
(2) benefits of disclosure
DES Compared to paper-based screening,
e-screening promotes greater disclosure
(for example, the mean score risk of
disclosure is significantly lower and
benefit of disclosure is significantly
higher in the e-screening group)
3. To determine factors associated with the
acceptability and feasibility of mental health
e-screening as well as disclosure
What factors are associated with
acceptability and feasibility of
mental health e-screening in
pregnant women?
Identification of factors that




variables (age, gestation, marital
status; ethnicity); (2) mental
health history; current mental
health status; EPDS scores;
ALPHA category; (3) DES scores;
(4) medical risk; (5) features of the
screening instrument/process
Factors that are significantly associated
with acceptability and feasibility: mental
health history, current mental health
status (EPDS, ALPHA), disclosure (DES),
medical risk; features of screening
instrument
Qualitative:














Table 1 Primary and secondary objectives, research questions, and hypotheses (Continued)
4. To compare the psychometric properties
(sensitivity, specificity, cutoff points) of
paper-based ALPHA and EPDS versus the
e-version administered to medically low-
and high-risk pregnant women
Are the psychometric properties
(for example, sensitivity, specificity,
cutoff points) similar or better in the
ALPHA and EPDS e-version compared
to the paper-version when administered
to pregnant women?
Psychometric properties: sensitivity,
specificity of ALPHA and EPDS in
paper-based and e-versions
ALPHA, EPDS, MINI The psychometric properties of e-version
of ALPHA and EPDS are similar or better
compared to paper-based version
5. To compare the cost-effectiveness
e-screening compared to paper-based
screening
Is e-screening as a component of routine
prenatal care cost effective when
compared to paper-based screening?
Cost-effectiveness: actual costs The expected incremental cost
effectiveness of e-screening is
cost effective at values of health
considered acceptable in the
Canadian healthcare system
E-screening will be cost effective














Figure 1 CONSORT trial flow diagram. *ALPHA: Antenatal Psychosocial Health Assessment; EPDS: Edinburgh Postnatal Depression Scale; MINI:
Mini International Neuropsychiatric Interview.
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use of symptom-based mental health screening tools,
the combined use of a psychosocial risk assessment in-
strument (for example, ALPHA) that detects current
and future risk for mental health problems and a symp-
tom screening tool (for example, EPDS) that detects
current symptomatology has been recommended as the
most effective, comprehensive approach to psychosocial
assessment [3].
The ALPHA was selected for use as a psychosocial risk
assessment tool because its paper-based version is cur-
rently used in our clinic recruitment sites. In addition,
the ALPHA is a Canadian-developed tool that has been
tested in the Canadian context in primary care [13,30]
and has been gaining popularity for antenatal psycho-
social assessment in these settings. It was designed to
identify psychosocial risk factors in pregnant women
that may increase their risk for adverse psychosocial out-
comes (for example, stressful life events, lack of sup-
port), including postpartum depression [50,51]. It has
undergone extensive face and content validity by experts
including obstetricians, family physicians, and midwives
[30], and identifies significantly more cases of psycho-
social risk than non-standardized assessment [51]. Themajority of providers indicated that the tool could read-
ily be implemented in routine prenatal care and preg-
nant women found it acceptable [33]. The self-report
version used in this study is easily completed in 5 to 10
minutes. It asks women questions on the topics of family
life, stressors, feelings about the pregnancy, substance
use, abuse, and family of origin. Women respond with
yes/no or 6-point Likert-scale options. Based on a review
of responses in each category, trained providers subject-
ively judge whether women are at low, some, or high
psychosocial risk. No cutoff points or scoring algorithm
have been developed and thus sensitivity and specificity
data are not available. Risk categories are then used to
create a care plan.
The 10-item EPDS was selected for evaluation because
it is one of the most widely used screening instruments
for postpartum, and less commonly, prenatal depression.
The EPDS was designed as a brief tool to screen for
postpartum depression symptoms within the previous 7
days [52]. A score of 13 or greater (range, 0 to 30) is a
well-established cutoff for clinically significant depres-
sion symptoms consistent with meeting criteria for a
major depressive episode [52]. Original psychometric
testing resulted in sensitivity of 85%, specificity of 77%,
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of 0.8, and a Cronbach’s alpha of 0.87 [52]. The 3-item
anxiety subscale of the EPDS is a reliable and valid tool
for probable anxiety using a cutoff of 4 or more with a
Cronbach’s alpha of 0.74, sensitivity of 66.7%, and speci-
ficity of 73.2% [35,53].
The control group
Women in the control group will complete paper-based
versions of the ALPHA and EPDS. Usual prenatal care
at our clinic recruitment sites involves women self-
completing the ALPHA on a single occasion during
pregnancy, typically while they wait for their first or sec-
ond prenatal visit. At the hospital recruitment site, usual
care does not include formal screening, although women’s
mental health status is monitored due to the high medical
risk. Paper-based screening was chosen as the comparator
because the primary objective of the study is to assess
feasibility and acceptability of the electronic administra-
tion of a psychosocial assessment.
Procedures
Maternity clinics At the maternity clinic recruitment
sites, each eligible woman will complete the ALPHA and
EPDS while they wait for their prenatal appointment -
either via computer tablet or paper. After randomization
to the control group, a message appears on the tablet,
directing women to complete the ALPHA and EPDS on
paper. An automatic ‘skip’ procedure ensures that the
electronic versions of the ALPHA and EPDS are bypassed
for women in the control group. Following completion of
the paper-based psychosocial assessment, women will
proceed to complete the baseline questionnaire on the
tablet. Women in the intervention group will be directed
to answer questions about emotional health (ALPHA and
EPDS) and the baseline questionnaire on the tablet. All
questions require responses, and thus women cannot
proceed past questions with missing answers until com-
pleted. In keeping with the current clinic processes of in-
cluding the assessment in the medical record, the
electronic copy will be printed following completion. As is
usual care in the maternity clinics, a Registered Nurse will
review the assessment, judge whether women are at low,
some, or high risk, discuss women’s psychosocial assess-
ment responses with them, and provide follow-up referrals
for those with some or high psychosocial risk with a men-
tal health nurse affiliated with the clinic.
Hospital-based antenatal unit In the antenatal unit,
the research assistant will meet with women who have
agreed to a follow-up contact by the research team. The
research assistant will provide the tablet, a copy of the
paper-based questionnaire, and an opaque envelope. The
research assistant will be available to answer questionsrelated to study participation, but then will leave the
room to allow the woman to proceed to the computer
randomization, and complete the assessment and base-
line questionnaire independently. Thus, the research as-
sistant will have no knowledge of the woman’s group
assignment. Following randomization to the intervention
group, women will be directed by a computer message
to complete the ALPHA and EPDS on the tablet as well
as the baseline questionnaire. Women assigned to the
control group will be directed by a computer message to
complete the ALPHA and EPDS on paper and then return
to the tablet for completion of the baseline questionnaire.
An automatic ‘skip’ procedure ensures that the electronic
versions of the ALPHA and EPDS are bypassed for
women in the control group.
In both cases, prior to the final submission of the
baseline questionnaire, intervention and control group
women will be prompted to place the paper-version
questionnaire in the opaque envelope and seal it.
In the antenatal unit setting, procedures to maintain
blinding of the research assistant are required because
he/she will be both recruiting women and conducting
the follow-up diagnostic interview. Blinding of the re-
search assistant is maintained by: (1) distributing an
opaque envelope and a paper-based version of the ALPHA
and EPDS to all participants prior to randomization; (2)
using a computer-based randomization process that re-
veals the assignment to the woman, but not the research
assistant; (3) instructing all women to return the paper-
based assessments to the envelope prior to giving the
tablet and envelope back to the research assistant (an elec-
tronic message on the tablet prompts women to return
the paper-based assessment to the envelope); and (4)
training the research assistant to return all envelopes (un-
opened) to the research coordinator.
Two processes have been designed to ensure that the
correct versions of the ALPHA and EPDS are completed
(for example, paper versus electronic) and to avert the
possibility that participants might self-select a preferred
version: (1) the electronic versions of the ALPHA and
EPDS are not available to women in the control group
through a programmed ‘skip’ procedure; and (2) the re-
search coordinator will conduct a manual check on a
subset of 30 control group participants at three different
times in the course of the study to ensure that paper-
based versions of the ALPHA and EPDS are completed.
If women are identified as meeting criteria for a mood
or anxiety disorder on the MINI International Neuro-
psychiatric Interview (see Confirmation of diagnosis) or
if they score 13 or more on the EPDS the research assist-
ant will create a referral for the woman (with her per-
mission) to the hospital-based reproductive mental
health support program and she will be followed up by a
mental health therapist.
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All women will have a MINI International Neuropsychi-
atric Interview (MINI, Version 6.0.0) by a trained,
blinded research team member skilled in diagnostic in-
terviews within 1 week of completing their psychosocial
assessment. The MINI is a brief, ‘gold standard’ diagnos-
tic interview designed to assess the presence of mental
disorders according to criteria defined in the Diagnostic
and Statistical Manual of Mental Disorders IV (DSM-IV)
[49]. It can be administered in approximately 15 minutes
with interviewees providing yes/no responses. All re-
search staff conducting diagnostic interviews will partici-
pate in four 3-hour training sessions on the structure
and completion of the MINI, interviewing skills, ap-
proaches to asking sensitive questions, and role-playing.
Additionally, the first two to three interviews will be su-
pervised by one of the mental health clinicians on our
team (KMH).
For women recruited through the maternity clinics, a
research team member not involved in recruitment will
conduct a telephone-based MINI within 1 week of the
woman completing the psychosocial assessment (at the
clinic). Because of space and time constraints in the ma-
ternity clinics, it is necessary to conduct the MINI via
telephone, and follow-up by a different research assistant
maintains blinding. For women recruited through the in-
patient antenatal unit, the MINI will be conducted at
the time of recruitment, after completion of the psycho-
social assessment and baseline questionnaire. The re-
search assistant involved in recruitment will conduct the
MINI, with specific measures employed to maintain
blinding (see Procedures).
Outcomes and measurement
Primary outcome The primary outcome is feasibility
and acceptability of screening (for example, e-screening
versus paper-based screening) (Table 1a).
Feasibility All women will complete the 10-item CASI
Assessment Evaluation (CAE), an established instrument
designed to evaluate the feasibility of computer-based
screening [40]. Originally designed to assess computer-
based screening of intimate-partner violence, the CAE’s
questions are relevant to assess feasibility of e-screening
for prenatal mental health, and its content is more ex-
tensive than measures used in other studies evaluating
different screening modalities in pregnant/postpartum
women [38]. The CAE has demonstrated face, construct,
and discriminant validity, and provides a standardized
assessment of feasibility of e-technology [40]. Women in
the intervention group will answer questions rating their
experience of e-screening. Women in the control group
will answer questions adapted from the CAE to assess
their views of e-screening (for example, ‘Would you havebeen comfortable using a computer tablet to answer these
questions?’).
Acceptability Questions adapted from other surveys of
mental health screening acceptability [24,25,54] will be
administered to women in both control and intervention
groups to evaluate acceptability of the form of screening
they completed. In addition, we will use semi-structured
face-to-face or telephone-based interviews to determine
views of feasibility and acceptability among a subset of
20 participants and 8 healthcare providers.
Secondary outcomes
The five secondary outcomes are (see measures in Table 1b):
(1)the proportion of pregnant women scoring 13 or
more on the total EPDS, 4 or more on the anxiety
subscale, and identified as some or high psychosocial
risk on the ALPHA;
(2)the level of disclosure as assessed by mean scores on
the Perceived Risk and Perceived Utility subscales of
the Disclosure Expectations Scale (DES) [55]. The
DES is an 8-item scale designed for evaluation of the
perceived risk (items 1, 2, 4, and 5) and benefit (items
3, 6, 7, and 8) of disclosure. Convergent validity of the
subscales has been demonstrated with other measures
of self-disclosure, as well as psychological distress, and
intention to seek mental healthcare [55];
(3)description of factors that significantly increase the
odds of acceptability, feasibility, and disclosure
related to each form of screening;
(4)psychometric properties (for example, Cronbach’s
alpha, sensitivity, specificity, positive and negative
predictive values) of the e-version of the EPDS and
ALPHA. A scoring algorithm does not currently exist
for the ALPHA (for example, the trained provider
subjectively judges risk based on responses); however,
an algorithm would promote standardization in
clinical decision-making and efficiency since a score
could be calculated as part of e-screening. We plan
further tool development comprising derivation of a
quantitative scoring method for classifying women
into psychosocial risk categories; and
(5)cost-effectiveness of detecting clinical depression
and anxiety in e-screening versus usual screening
(that is, equipment and human resource costs of
e-screening versus paper-based - see Secondary
outcomes).
Sample size
Determination of sample size Because no data are avail-
able to guide estimation of a minimal clinically important
difference in ‘true’ cases detected through e-screening a
‘confidence interval (CI) approach’ [56] was used. Based
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using computer screening [39,40], e-screening would be
feasible if, in the intervention group: (1) 85% of women in-
dicated that they were able to tell the truth on all items
(Q7 CAE); (2) 85% scored 4 to 8 on the Risk subscale of
the DES (no/slight perceived risk to disclosure); and (3)
85% scored 16 to 20 on the DES Utility subscale (for ex-
ample, disclosure moderately or very beneficial). The sam-
ple size calculation (Table 2) indicates that 261 women
per group (n = 522) is required.
Feasibility of achieving sample size The maternity clinics
conduct initial prenatal visits for a total of 50 women per
month across all clinics. The number of new patients on
the high-risk antenatal unit is similar at 45 women per
month. Clinic staff estimates that roughly 4% of women
would be ineligible due to language (96% eligible = 91
women per month). A conservative estimation of 50% par-
ticipation rate [57,58] would yield 46 women per month.
Thus, recruitment of women is expected to take 12
months.
Data collection procedures
Procedures related to completion of the psychosocial as-
sessment and baseline questionnaire are described in
Procedures. Women will complete the psychosocial as-
sessment on a single occasion. The content and order of
individual questions in the e-version of the instruments
will be identical to the paper-based version. Women se-
lect responses by touching the screen. If a woman does
not answer a question, she will be prompted to respond
before she can proceed. This is to mimic the usual
screening process where the nurse would ask the woman
to respond to a missing answer. A ‘SUBMIT’ button at
the bottom of the baseline questionnaire will allow
women to submit their responses.
The order of material on the tablet will be: (1) Partici-
pant Information Letter and Consent; (2) preamble de-
scribing the importance of screening and the follow-up
with the healthcare provider; (3) ALPHA and EPDS; (4)
the CAE, DES, and questions related to acceptability,
feasibility, and disclosure; and (5) baseline questionnaire.
The content of the baseline questionnaire includes ques-
tions that represent factors associated with prenatalTable 2 Sample size determination
Using the calculation of a confidence interval for a proportion,
a 95% CI and a margin of error of 0.05:
A
o
p = a priori estimate of % of interest; n = sample size n
n = p(1-p) [1.96/.05]2 N
n = 0.85(1–0.85) [39.2]2 N
n = 196 N
Therefore a minimum of 261 women per group would be required.mental health or disclosure of mental health concerns,
and includes: (1) demographics (age, parity, marital sta-
tus, education, income, ethnicity, country of birth, and
length of time in Canada); (2) obstetrical history (current
and past, including use of fertility treatments); (3) men-
tal health history (diagnoses, treatment); (4) level of
comfort with technology (for example, laptop, tablet); (5)
quality of relationship with perinatal care provider; (6)
level of social support, experience of talking with doc-
tor/nurse/midwife about emotional health; and (7) ad-
verse childhood experiences (using ACES questionnaire
[48]). With the exception of the ACES (http://acestudy.
org/ace_score), questions were derived from the All Our
Babies longitudinal birth cohort study (http://www.prehot.
org/The%20All%20Our%20Babies%20Study/) and the Ma-
ternity Experiences Survey (http://www.phac-aspc.gc.ca/
rhs-ssg/survey-eng.php). Participants are required to an-
swer all fields except for income, thus limiting the issue of
missing data. Data for the economic evaluation will be col-
lected from program accounts for technology and soft-
ware costs, and by interviewing clinic staff to estimate
clinic operation costs for the two alternatives. We will use
a healthcare perspective and all costs will be shown in
2014 values.
No data will be stored on the tablets. When women
‘submit’ their information it will be sent to a secure ser-
ver housed in the Faculty of Medicine & Dentistry’s Data
Centre at the University of Alberta. The psychosocial as-
sessment and questionnaire were built using an existing
infrastructure offered by Checkbox Survey software pro-
vided by Women’s and Children’s Health Research Insti-
tute’s (WCHRI) Clinical Research Informatics. Data
transfer between the tablet and server will be encrypted.
Data imported to statistical databases for analysis will
not be identifiable.
Analysis
Primary outcome and description of sample
Intention-to-treat analysis will be conducted for all ana-
lyses. We will use descriptive data (frequencies/95% CI;
means/standard deviation) to describe the sample. Baseline
differences in groups will be compared using independent
t-tests (means) and chi-square tests (%) to determine the
extent to which randomization was successful. Statisticalccounting for an estimated attrition/loss to follow-up of 25% based
n other reported rates in pregnant and postpartum women (55,66):
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http://www.trialsjournal.com/content/15/1/3significance for all analyses is set at P <0.05. We will use
two-tailed independent t-tests to compare intervention
and control group differences in mean scores of the CAE
and chi-square tests to compare proportions of women in
each group responding affirmatively to questions on feasi-
bility and acceptability.
Secondary outcomes
Detection Differences in proportions of women in the
control and intervention group scoring 13 or more on
the EPDS, and categorized as some or high-risk on the
ALPHA will be estimated using chi-square tests.
Disclosure Comparison of mean scores of the subscales
of the DES (risk, benefit of disclosure) will be done using
two-tailed independent sample t-tests.
Factors associated with acceptability, feasibility, and
disclosure We will use multivariable logistic regression
to determine predictors of acceptability, feasibility, and
disclosure and report relative risks and 95% CIs. Out-
comes will be dichomotized measures of acceptability,
feasibility (based on CAE), and disclosure (based on
DES) where ‘high’ acceptability, feasibility, and disclosure
will include participants whose responses place them
above the 75th percentile for the measure. Models will
be built using variables that are associated with out-
comes at P <0.10 on crude analyses, entering demo-
graphic variables in a first block, followed by obstetrical
factors, mental health history, and the ACES score. Re-
sults will be reported as odds ratios and 95% CIs.
Psychometric properties Psychometric properties of in-
ternal consistency (Cronbach’s alpha; item-total correl-
ation) will be calculated for the EPDS by modality.
Predictive validity measures of sensitivity, specificity,
positive predictive value, and negative predictive value
will be calculated using clinical interview diagnosis as
the reference. Comparisons of the psychometrics be-
tween the two modalities will be made by correlational
analysis using Cohen’s guidelines [59]. In terms of fur-
ther tool development of the ALPHA, we will develop
an integer score-based prediction rule for the prevalence
of anxiety and depression, according to MINI diagnosis.
This method was previously used to develop a prenatal
screening tool for postpartum distress by two members
of the research team (SM, DK) [60]. We will develop a
best fit multiple regression model predicting depression
and/or anxiety as per clinical interview diagnosis, candi-
date variables for which will be drawn from the ALPHA.
A regression coefficient-based scoring algorithm [60]
will be applied to the final regression model in order to
develop a single screening score. Receiver operating char-
acteristic (ROC) analysis will then be used to determinean optimal cutoff for the screening score. Finally, we will
perform a ROC analysis for each modality (e-version
versus paper-based) and compare indices of sensitivity,
specificity, positive and negative predictive values using
Cohen’s guidelines [60]. All analyses will be conducted in
the total sample, with subgroup analyses conducted by
medical risk to determine whether the scoring is robust
across risk subgroups.
Cost-effectiveness For the economic analysis, we will
estimate the incremental costs-effectiveness (ICER) for
the e-screening alternative compared to the paper-based
alternative. The e-screening costs include investment
costs to technology (programs, tablets, data storage) and
the operating costs at the clinic that may differ some-
what from the conventional group administrative and
analytical cost. Cost-effectiveness is determined by incre-
mental cost to identify a woman with increased risk of
prenatal and postpartum depression and anxiety. Be-
cause we are not going to follow up the screened
women, the costs and outcomes after the screening are
not included in this initial economic analysis.
Qualitative descriptive study
Methods
Participant eligibility and recruitment
All women and healthcare providers working at the
study sites are eligible for participation in the qualitative
component. Purposeful sampling will be used to
maximize variability in the sample, ensuring that a broad
range of views and demographic (for example, income
age, marital status, ethnicity), medical (for example,
mental health history; current mental health status), and
social (ACES) factors are represented [61]. We plan to
interview approximately 20 women (10 intervention
group, 10 control group) and eight to 10 providers (for
example, nurses, family physicians) with the final sample
size determined by data saturation. Women will be in-
vited by the research assistant to participate in a follow-
up qualitative interview during the diagnostic interview.
Healthcare providers will be invited through emails dis-
tributed by the managers.
Data collection and management
We will conduct individual face-to-face and telephone-
based interviews. Semi-structured interview guides will
be used [61] to ask participants their views on the feasi-
bility and acceptability of screening by e-screening or
paper-based version (depending on group membership),
as well as its strengths, suggestions for improvement,
and the challenges and benefits they experienced. Inter-
views are expected to take 30 to 60 minutes and will be
digitally recorded and transcribed verbatim. Transcribed
interviews and digital files will be stored in the secure
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http://www.trialsjournal.com/content/15/1/3environment of the Health Research Data Repository at
the University of Alberta. All data will be anonymized
for publication. Only researchers affiliated with the study
will have access to participant data.
Analysis
As recommended for qualitative descriptive studies, we
will use standard qualitative content analysis approaches
for thematic analysis of the transcripts [61]. Two mem-
bers of the team experienced in qualitative data analysis
will independently code the first two or three transcripts
and attain consensus on a coding scheme. These two
team members will use this coding scheme to analyze
two to three more transcripts, and a revised coding
scheme will be established as necessary. The well-
developed coding scheme will then be refined to the
point where one research team member can independ-
ently code the remaining transcripts, with revisions
made as necessary to reflect new and evolving themes as
data analysis progresses [61]. Thematic analysis will occur
concurrently with data collection to allow further explor-
ation and clarification of emergent ideas, and data collec-
tion will continue until data saturation is reached [62].
Conclusion
This study will: (1) determine the acceptability and feasi-
bility of widespread e-screening in routine prenatal care
across different risk subgroups; (2) improve pregnant
women’s mental health through increased access to early
screening and treatment; (3) inform future trials of e-
screening in different perinatal (for example, midwife,
obstetrician) and home-based settings; and (4) inform
policy development through data regarding the clinical
value of psychosocial assessment across varied practice
settings and potentially the ease, accuracy, and accept-
ance of electronic data collection regarding sensitive per-
sonal information with pregnant women.
Trial status
Recruitment will begin in September 2013.
Trial registration: ClinicalTrials.gov Identifier: NCT01899534.
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